FOXP2: Difference between revisions

From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs)
No edit summary
David Canner (talk | contribs)
No edit summary
Line 1: Line 1:
<StructureSection load='2a07' size='500' side='right' caption='Structure of FOXP2, [[2a07]]' scene='FOXP2/Opening/1'>
<StructureSection load='2a07' size='500' side='right' caption='Structure of FOXP2, [[2a07]]' scene='FOXP2/Opening/1'>
[[Image:FOXP22.png|250px|left]]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[[FOXP2]] is a family of forkhead transcription factors, which are part of a larger [[Forkhead box family]] of proteins. They play a crucial role in the development of the areas of the brain responsible for  language and speech.  In the 1990s, a family  of individuals called the “KEs”, all of whom suffer from the same speech and language disorder, were discovered to be heterozygous for FOXP2 due to a mutation in one of their chromosomes. It has been suggested that the KEs lacked necessary concentrations of FOXP2 at critical times during their fetal brain development preventing the areas important for speech to develop.<ref>PMID: 11586336</ref> Nonfunctional FOXP2 alleles have been found to cause disruption of the striatum, a part of the basal ganglia responsible for speech. Further, spiny neurons within the striatum were found to have increased dendrite lengths and increased synaptic plasticity when FOXP2 mutant alleles were present, possibly causing the speech dysfunction. FOXP2 also has evolutionary implications. Two well-known amino acid substitutions, T303N and N325S appear to be the major substitutions in FOXP2 which separate the speech development patterns of chimpanzees and humans. Mouse models incorporating these mutations in FOXP2 demonstrated dramatically different ultrasonic vocalizations and decreased dopamine concentrations supporting FOXP2s involvement in the basal ganglia.<ref>PMID: 19490899</ref> The improper speech development associated with FOXP2 mutations are reminiscent of symptoms associated with [[autism]] and highlights a potential new target for [[Pharma drugs|therapeutic intervention]].  
[[Image:FOXP22.png|250px|left]]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[[FOXP2]] is a family of forkhead transcription factors, which are part of a larger [[Forkhead box protein|Forkhead box family]] of proteins. They play a crucial role in the development of the areas of the brain responsible for  language and speech.  In the 1990s, a family  of individuals called the “KEs”, all of whom suffer from the same speech and language disorder, were discovered to be heterozygous for FOXP2 due to a mutation in one of their chromosomes. It has been suggested that the KEs lacked necessary concentrations of FOXP2 at critical times during their fetal brain development preventing the areas important for speech to develop.<ref>PMID: 11586336</ref> Nonfunctional FOXP2 alleles have been found to cause disruption of the striatum, a part of the basal ganglia responsible for speech. Further, spiny neurons within the striatum were found to have increased dendrite lengths and increased synaptic plasticity when FOXP2 mutant alleles were present, possibly causing the speech dysfunction. FOXP2 also has evolutionary implications. Two well-known amino acid substitutions, T303N and N325S appear to be the major substitutions in FOXP2 which separate the speech development patterns of chimpanzees and humans. Mouse models incorporating these mutations in FOXP2 demonstrated dramatically different ultrasonic vocalizations and decreased dopamine concentrations supporting FOXP2s involvement in the basal ganglia.<ref>PMID: 19490899</ref> The improper speech development associated with FOXP2 mutations are reminiscent of symptoms associated with [[autism]] and highlights a potential new target for [[Pharma drugs|therapeutic intervention]].  


====Structure of Monomeric FOXP2====
====Structure of Monomeric FOXP2====

Revision as of 01:45, 26 April 2012

Structure of FOXP2, 2a07

Drag the structure with the mouse to rotate

Page Development

This article was developed based on lectures given in Chemistry 543 by Prof. Clarence E. Schutt at Princeton University.

References


See Also

Proteopedia Page Contributors and Editors (what is this?)

David Canner, Wayne Decatur, Alexander Berchansky, Michal Harel